Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A G Dalgleish

Showing results (81-90 of 222) with videos related to

Pageof 23
Sort By:
British Journal of Urology|March 1, 1997
The role of immunotherapy for urological tumoursD Hrouda, G H Muir, A G Dalgleish
Clinical and Experimental Immunology|September 6, 2000
Thalidomide analogue CC-3052 reduces HIV+ neutrophil apoptosis in vitroM Guckian, I Dransfield, P Hay, et al.
Expert Opinion on Investigational Drugs|July 5, 2005
The role of herpes simplex virus thymidine kinase in the treatment of solid tumoursM J Perry, S M Todryk, A G Dalgleish
Lancet (London, England)|October 10, 1987
Inhibition of HIV replication in vitro by fusidic acidV Faber, A G Dalgleish, A Newell, et al.
Medical and Pediatric Oncology|January 1, 1984
Bleomycin pulmonary toxicity: its relationship to renal dysfunctionA G Dalgleish, R L Woods, J A Levi
Neuropathology and Applied Neurobiology|July 1, 1987
Do human T-lymphotrophic viruses (HTLVs) and other enveloped viruses induce autoimmunity in multiple sclerosis?A G Dalgleish, J K Fazakerley, H E Webb
Clinical and Experimental Immunology|July 27, 2001
Inhibition of p38 MAP kinase during cellular activation results in IFN-gamma-dependent augmentation of IL-12 production by human monocytes/macrophagesJ B Marriott, I A Clarke, A G Dalgleish
Journal of Acquired Immune Deficiency Syndromes|December 1, 1994
Absence of GVH diseases in AIDSJ A Habeshaw, A G Dalgleish, E F Hounsell
Clinical and Experimental Immunology|November 1, 1988
The interleukins in acquired diseaseM Malkovský, P M Sondel, W Strober, et al.
The Journal of Hospital Infection|April 1, 1990
Evaluation of hypochlorite-releasing disinfectants against the human immunodeficiency virus (HIV)S F Bloomfield, C A Smith-Burchnell, A G Dalgleish
Pageof 23

Showing results (81-90 of 222) with videos related to

Sort By:
Pageof 23
British Journal of Urology|March 1, 1997
The role of immunotherapy for urological tumoursD Hrouda, G H Muir, A G Dalgleish
Clinical and Experimental Immunology|September 6, 2000
Thalidomide analogue CC-3052 reduces HIV+ neutrophil apoptosis in vitroM Guckian, I Dransfield, P Hay, et al.
Expert Opinion on Investigational Drugs|July 5, 2005
The role of herpes simplex virus thymidine kinase in the treatment of solid tumoursM J Perry, S M Todryk, A G Dalgleish
Lancet (London, England)|October 10, 1987
Inhibition of HIV replication in vitro by fusidic acidV Faber, A G Dalgleish, A Newell, et al.
Medical and Pediatric Oncology|January 1, 1984
Bleomycin pulmonary toxicity: its relationship to renal dysfunctionA G Dalgleish, R L Woods, J A Levi
Neuropathology and Applied Neurobiology|July 1, 1987
Do human T-lymphotrophic viruses (HTLVs) and other enveloped viruses induce autoimmunity in multiple sclerosis?A G Dalgleish, J K Fazakerley, H E Webb
Clinical and Experimental Immunology|July 27, 2001
Inhibition of p38 MAP kinase during cellular activation results in IFN-gamma-dependent augmentation of IL-12 production by human monocytes/macrophagesJ B Marriott, I A Clarke, A G Dalgleish
Journal of Acquired Immune Deficiency Syndromes|December 1, 1994
Absence of GVH diseases in AIDSJ A Habeshaw, A G Dalgleish, E F Hounsell
Clinical and Experimental Immunology|November 1, 1988
The interleukins in acquired diseaseM Malkovský, P M Sondel, W Strober, et al.
The Journal of Hospital Infection|April 1, 1990
Evaluation of hypochlorite-releasing disinfectants against the human immunodeficiency virus (HIV)S F Bloomfield, C A Smith-Burchnell, A G Dalgleish
Pageof 23